Elcar, 300 mg/ml 25 ml

Pharmacological action is metabolic. Participates in metabolic processes as a carrier of long-chain fatty acids (palmitic acid, etc.) from cytoplasm to mitochondria, where these acids undergo β-oxidation process with formation of adenosine triphosphoric acid and acetyl-CoA.
It improves protein and fat metabolism, increases secretion and enzymatic activity of gastric and intestinal juices, improves digestion, reduces excessive body weight and muscle fat content. It increases resistance to physical activity, inhibits ketoacid formation and anaerobic glycolysis, reduces lactacidosis, promotes economical use of glycogen and increases its reserves in the liver and muscles.
Anabolic and lipolytic effect. It normalizes elevated basal metabolism in hyperthyroidism: it is a peripheral (indirect) antagonist of thyroid hormones, rather than a direct inhibitor of thyroid function. It improves metabolism and tissue energy supply.< /p>

Indications

Weakness and fatigue, Psycho-emotional stress, Concussion and other brain injuries, Eczema, Period of recovery, Low capacity for work, Gastritis, Psoriasis, Headache, Malnutrition, Intensive physical activity, Chronic pancreatitis, Hyperthyroidism

In the complex therapy:

• intensive physical activity and psycho-emotional stress: to improve performance, endurance, reduce fatigue, including.
• in rehabilitation period after diseases and surgery, trauma, including.
• complex therapy of skin diseases (psoriasis, seborrheic eczema, focal scleroderma, lupus discoidus);
• complex therapy of chronic gastritis with decreased secretory function and chronic pancreatitis with external secretory insufficiency;
• hyperthyroidism of mild degree;
• neurological manifestations in brain lesions of vascular, toxic and traumatic genesis;
• anorexia nervosa syndrome;
• diseases accompanied by a lack of or increased loss of carnitine (including.ч.
• Diseases accompanied with deficiency or increased loss of carnitine (including myopathies, cardiomyopathies, mitochondrial diseases, hereditary diseases with associated mitochondrial deficiencies) – for making up for its deficiency in combination therapy.

In pediatric practice (treatment of children under 3 years of age under medical supervision):

• care for premature and newborns who have suffered birth trauma or asphyxia;
• In children with sluggish sucking reflex and low weight gain, reduced muscle tone, insufficient development of motor and mental functions, and to prevent these disorders in children at risk;
• In delayed growth and underweight children and teenagers under the age of 16.

In adults in sports medicine and in intensive training (during the training process in the development of aerobic performance):

• to improve speed and strength performance and movement coordination;
• to increase muscle mass and reduce body fat;
• for prevention of post-training syndrome (accelerated recovery processes after physical activity);
• in case of traumatic injuries to accelerate muscle regeneration.

.

Active ingredient

Levocarnitine

Composition

Active ingredient: levocarnitine (carnify) 300 mg.

Auxiliary substances: citric acid monohydrate 1.2 mg, methyl parahydroxybenzoate 0.5 mg, propyl parahydroxybenzoate 0.2 mg, purified water up to 1 ml.

How to take, the dosage

The drug is used as part of the complex therapy. Orally, 30 minutes before the meal, diluted with liquid.
In case of long physical and psycho-emotional strain, from 0.75 g (1/2 scoop or 2.5 ml) 3 times a day to 2.25 g (1.5 scoops or 7.5 ml) 2-3 times a day.
Anorexia nervosa and also during rehabilitation after the diseases and surgical interventions and injuries: 1.5 g (1 scoop or 5 ml) 2 times a day. The course of treatment is 1-2 months.
In the treatment of chronic gastritis and chronic pancreatitis with decreased secretory function: 0.375 g (1/4 scoop or 1.25 ml) 2 times a day. The course of treatment is 1-1.5 months.
The treatment of skin diseases: 0.75 g (1/2 scoop or 2.5 ml). The course of treatment is 2-4 weeks.
Hyperthyroidism of mild degree: 0.25 g (13 drops), 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after 1-2 months of break or it is prescribed for 3 months without break.
Avascular, toxic and traumatic brain damage: 0.75 g (1/2 scoop or 2.5 ml) a day. The course of treatment is 3-5 days. If necessary the second course of treatment is prescribed in 12-14 days.
In diseases accompanied by carnitine deficiency (primary and secondary carnitine deficiency): up to 50-100 mg/kg (2-5 drops/kg) of body weight with a multiplicity of administration 2-3 times a day. The course of treatment is 3-4 months. Stun: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment may be repeated after 1-2 months break or it may be prescribed for 3 months without break.
In sports medicine and intensive training: 2.5 g 1-3 times a day (daily dose of 2.5 – 7.5 g). If used for therapeutic purposes – 70-100 mg/kg/day (5-7.5 g/day). The course of treatment: 3-4 weeks in the pre-competition period. During the training process – up to 6-8 weeks.

Interaction

Glucocorticosteroids contribute to the accumulation of the drug in tissues (except the liver), other anabolics enhance the effect.

Special Instructions

Treatment of children under 3 years of age should be carried out under the supervision of a physician.
Impact on the ability to drive and operate machinery: The drug has no effect on performance of potentially hazardous activities requiring particular attention and quick reactions (driving a car and other vehicles, working with moving mechanisms, work of dispatcher and operator, etc.)

The drug does not affect the performance of potentially hazardous activities requiring particular attention and quick reactions.

Contraindications

Individual intolerance to the components of the drug.

Side effects

Possible: allergic reactions, gastralgia, dyspepsia, myasthenia (in patients with uremia).

Overdose

Symptoms: dyspeptic disorders, myasthenic disorders (in patients with uremia).
Treatment: gastric lavage, intake of activated charcoal.

Pregnancy use

Pregnancy is contraindicated due to a lack of studies. Breast-feeding should be stopped while the drug is being used.

Similarities

El Carnitine, Carnitine, Levocarnil